TempraMed TechnologiesFRA:9DY +33.63%1 OCF Yield % is -13.68 as of Jul. 07, 2026. GuruFocus rates FRA:9DY with a GF Score™ of 1/100. The stock has 5 warning signs investors should review. Among 853 Medical Devices & Instruments companies, TempraMed Technologies ranks worse than 81.01% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for TempraMed Technologies's OCF Yield % or its related term are showing as below:
FRA:9DY'
s OCF Yield % Range Over the Past 10 Years
Min: -13.91 Med: -8.19 Max: -3.6
Current: -13.68
During the past 3 years, the highest OCF Yield % of TempraMed Technologies was -3.60%. The lowest was -13.91%. And the median was -8.19%.
FRA:9DY's OCF Yield % is ranked worse than 81.01% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 1.7
vs FRA:9DY: -13.68
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
TempraMed Technologies OCF Yield % Related Terms
TempraMed Technologies OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, TempraMed Technologies's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TempraMed Technologies OCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, TempraMed Technologies's OCF Yield % distribution charts can be found below:
* The bar in red indicates where TempraMed Technologies's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TempraMed Technologies (FRA:9DY) has a OCF Yield % of -13.68 as of Jul. 07, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on TempraMed Technologies and its competitors. According to the industry distribution chart, TempraMed Technologies ranks #691 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 81%.
Is TempraMed Technologies' OCF Yield % too high?
TempraMed Technologies' current OCF Yield % is -13.68. Based on the distribution chart, TempraMed Technologies ranks #691 out of 853 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, TempraMed Technologies has a GF Score™ of 1/100, reflecting its overall financial health beyond just this single metric.
How does TempraMed Technologies' OCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, TempraMed Technologies ranks #691 out of 853 companies for OCF Yield %. This places TempraMed Technologies in the lower half of its industry. The industry median OCF Yield % is 1.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.70, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on TempraMed Technologies and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TempraMed Technologies's current OCF Yield % is -13.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TempraMed Technologies stock overvalued right now?
TempraMed Technologies (FRA:9DY) has a current OCF Yield % of -13.68. The current OCF Yield % is -13.68. TempraMed Technologies' overall GF Score™ is 1/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For TempraMed Technologies (FRA:9DY), the current OCF Yield % is -13.68 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
TempraMed Technologies Ltd through its subsidiary, engaged in developing patent-protected technology designed to serve a broad range of medical and consumer products. TempraMed's primary focus is revolutionizing storage and management of injectable for temperature-sensitive medications. This inventive technology ensures adequate temperature storage conditions to medications without requiring power source or human intervention for years.
1GF Score
Get the complete analysis for FRA:9DY
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:9DY has been successfully added to your 
